Omnicell's Industry-Leading Medication Management Automation Platform and Solutions to Be Featured at HIMSS18
MOUNTAIN VIEW, Calif., Feb. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will feature its award-winning platform of solutions at the HIMSS18 Conference & Exhibition, taking place March 5-9 in Las Vegas. Omnicell's industry-leading medication management platform leverages automation and predictive analytics to improve patient safety, simplify workflows, and decrease costs across health systems.
According to a recent report from the PwC Health Research Institute, three-quarters of healthcare executives plan to invest in artificial and predictive intelligence in the next three years.i Although applying these technologies to medication management in the hospital can help reduce the impact of drug shortages and price increases, only 20 percent of respondents believe they have the ability to implement and achieve success with this technology. Omnicell helps healthcare facilities maximize the benefits of such technology investments, leveraging real-time, cloud-based reporting, analytics, and benchmarking to drive more strategic decision making, while freeing up time for healthcare providers to refocus from administrative tasks to making clinical contributions.
Omnicell's analytics tools and workflow solutions will be on display at HIMSS18 in booth #1629. These include:
For the first time at HIMSS, Omnicell will be featuring the recently announced Omnicell® XR2 Automated Central Pharmacy System and Omnicell IVX Workflow. The XR2 system uses robotic technology to eliminate numerous manual tasks, allowing pharmacy to redirect resources to clinical activities that have meaningful impacts on patient outcomes. By automating critical workflows in the central pharmacy, XR2 helps drive efficiencies, minimize human error, and enable more accurate management of inventory levels.
IVX Workflow is an innovative sterile compounding workflow solution that incorporates integrated barcode scanning, gravimetric or volumetric verification, advanced image recognition, photo documentation, and label printing as part of a compact all-in-one package. It is designed to support safe, accurate, and streamlined IV sterile compounding. IVX Workflow is powered by Omnicell® IVX Cloud, a web-based software suite designed to manage all aspects of IV compounding workflow operation across a hospital or health system.
In addition, Omnicell will be hosting a reception and panel discussion titled "Digital Transformation Using Interoperability, Machine Learning and Predictive Analytics in the Healthcare Environment with the Impact on Medication Safety" on Tuesday, March 6 from 6 p.m.-8 p.m. at the Venetian Sands Convention Center, Room 201.
Scheduled panelists include:
Dr. Shafiq Rab, MD
Dr. Eric A. Williams, MD
Omnicell's Performance Center will also be featured in the Interoperability Showcase, located on Level 1 in Hall G. Omnicell will partner with Epic, B Braun, GuardRFID, and Philips in a Use Case titled "Diabetes and Cardiovascular Risk Factors." The case follows individuals with multiple comorbidities, such as diabetes and heart disease, as they face challenges moving through the healthcare system.
"As hospitals continue to look for ways to raise the level of care, we are proud to offer our hospitals and health system partners a broad portfolio leveraging the latest innovative technologies that can be integrated throughout their facilities," said Nhat H. Ngo, executive vice president, marketing, strategy & business development at Omnicell. "We're excited to be at HIMSS18 and showcase how we can work with healthcare providers to reduce manual processes, allowing them to maximize their resources and help positively impact patient outcomes."
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
i Healthcare IT News. "Here are the 12 healthcare issues that will define 2018, according to PwC." (Accessed 2/15/18). http://www.healthcareitnews.com/news/here-are-12-healthcare-issues-will-define-2018-according-pwc
View original content with multimedia:http://www.prnewswire.com/news-releases/omnicells-industry-leading-medication-management-automation-platform-and-solutions-to-be-featured-at-himss18-300604827.html
SOURCE Omnicell, Inc.
Company Codes: NASDAQ-NMS:OMCL